Drug of choice for palliative treatment of pancreatic carcinoma
**Core Concept:** Palliative treatment aims to relieve symptoms and improve the quality of life in patients with advanced or incurable diseases like pancreatic carcinoma. This involves managing pain, nausea, vomiting, and other complications effectively.
**Why the Correct Answer is Right:** In palliative treatment of pancreatic carcinoma, **D**oxifluridine (5-FU) is often chosen. 5-FU is a pyrimidine analogue that interferes with DNA and RNA synthesis in rapidly dividing cancer cells, leading to cell death. It is administered orally or intravenously and has shown efficacy in controlling symptoms like pain, nausea, and vomiting, as well as slowing down tumor growth.
**Why Each Wrong Option is Incorrect:**
A. **Palliative Radiation Therapy (RT)** is primarily used to relieve symptoms like pain, obstruction, and bleeding caused by pancreatic carcinoma. While it can provide temporary symptom relief, it is not a cure for the cancer itself.
B. **Hormonal Therapy (e.g., Gastrin Receptor Antagonists)** targets hormonal imbalances associated with tumor-induced gastrointestinal symptoms, but it is not a primary treatment for pancreatic carcinoma.
C. **Nutritional Support** is important for maintaining body weight, preventing cachexia, and improving quality of life, but it is not a direct treatment for the cancer.
**Clinical Pearl:** In pancreatic carcinoma, a combination of chemotherapeutic agents like 5-FU, gemcitabine, and radiation therapy may be used to achieve better symptom control and survival benefits compared to monotherapy. However, the question specifically asks for a single drug, making 5-FU the best choice among the options provided.
**Correct Answer:** D. 5-FU (doxifluridine) is the drug of choice for palliative treatment of pancreatic carcinoma as it provides symptom relief (pain, nausea, vomiting) and has shown some tumor growth inhibition.